Intec Pharma Ltd. (NASDAQ:NTEC) and Novelion Therapeutics Inc. (NASDAQ:NVLN) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation.
Valuation and Earnings
Table 1 shows top-line revenue, earnings per share and valuation of the two companies.
Table 2 shows us the net margins, return on assets and return on equity of both companies.
Insider Institutional Ownership
Intec Pharma Ltd. and Novelion Therapeutics Inc. has shares held by institutional investors as follows: 39.64% and 48.8%. Intec Pharma Ltd.’s share held by insiders are 11.81%. On the other hand, insiders held about 0.8% of Novelion Therapeutics Inc.’s shares.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Intec Pharma Ltd. has weaker performance than Novelion